A Rapid and Improved Method to Generate Recombinant Dengue Virus Vaccine Candidates

• Dhanasekaran Govindarajan,

  Affiliation Merck Research Laboratories, Merck & Co., Kenilworth, NJ, United States of America

  ⨯
• Liming Guan,

  Affiliation Merck Research Laboratories, Merck & Co., Kenilworth, NJ, United States of America

  ⨯
• Steven Meschino,

  Affiliation Merck Research Laboratories, Merck & Co., Kenilworth, NJ, United States of America

  ⨯
• Arthur Fridman,

  Affiliation Merck Research Laboratories, Merck & Co., Kenilworth, NJ, United States of America

  ⨯
• Ansu Bagchi,

  Affiliation Merck Research Laboratories, Merck & Co., Kenilworth, NJ, United States of America

  ⨯
• Irene Pak,

  Affiliation Merck Research Laboratories, Merck & Co., Kenilworth, NJ, United States of America

  ⨯
• Jan ter Meulen,

  Affiliation Immune Design Corporation, Seattle, WA, United States of America

  ⨯
• Danilo R. Casimiro,

  Affiliation Merck Research Laboratories, Merck & Co., Kenilworth, NJ, United States of America

  ⨯
• Andrew J. Bett

  * E-mail: andrew_bett@merck.com

  Affiliation Merck Research Laboratories, Merck & Co., Kenilworth, NJ, United States of America

  ⨯